Overview
Guidance is urgently needed for disease endemic countries (DEC) to take advantage of the possible benefits of innovative genetic control of mosquito vectors of human diseases. Approximately 50% of the world’s population, mostly those living in the world’s poorest countries, are at risk of malaria or dengue fever.
The overall goal of the MosqGuide project is to develop and validate best practice guidance relating to the range of requirements for deployment of genetically modified (GM) mosquitoes to control mosquito-vectored disease, specifically malaria and dengue.
Drawing on risk/benefit methodologies from related fields, extensive consultation and personal experience in this novel field, the project aims to develop a modular approach on best practices for testing, import, deployment and monitoring of genetically modified mosquitoes designed for the control of malaria and dengue.